Fig. 4From: Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysisMeta-analysis of the overall survival rate (OS) (a), progression-free survival (PFS) (b), and local control (LC) (c) at 5 yearBack to article page